Clinical Trial Update: Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer：MetBio-GC

View source ↗

Summary

A clinical trial to develop and validate metabolic biomarkers for early diagnosis, prognosis, and recurrence of gastric cancer is currently recruiting in Shangh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: Shanghai Minimally Invasive Surgery Center | Conditions: Gastric Cancer | Status: RECRUITING